Lotus Eye Hospital And Institute share price

High risk
  • 47%Low risk
  • 47%Moderate risk
  • 47%Balanced risk
  • 47%High risk
  • 47%Extreme risk
  • ₹65.97(0.29%)
    April 17, 2025 15:29:26 PM IST
    • NSE
    • BSE
  • Vol : 19.75K (NSE + BSE)
    Last 20 day avg : 69.76 K

Lotus Eye Hospital And Institute is trading 0.29% upper at Rs 65.97 as compared to its last closing price. Lotus Eye Hospital And Institute has been trading in the price range of 67.00 & 65.40. Lotus Eye Hospital And Institute has given -0.92% in this year & -1.02% in the last 5 days. Lotus Eye Hospital And Institute has TTM P/E ratio 264.78 as compared to the sector P/E of 22.83.The company posted a net profit of -0.24 Crores in its last quarter.Listed peers of Lotus Eye Hospital And Institute include Aashka Hospitals (-%), Fortis Malar Hospitals (0.07%), Lotus Eye Hospital And Institute (0.29%).The Mutual Fund holding in Lotus Eye Hospital And Institute was at -% in . The MF holding has - from the last quarter. The FII holding in Lotus Eye Hospital And Institute was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Apr 20, 2025, 12:01 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.31
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    262.36
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.72
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
65.40
Highest
67.00
52 week range
Lowest
53.00
Highest
91.00
Lotus Eye Hospital And Institute Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is not profitable
    • financial-insightsThe company's revenue grew in December quarter by 1.80% from Rs 12.25 crore to Rs 12.03 crore, year-on-year
    • financial-insightsCompany has registered a loss of 0.24 cr vs a profit of 0.66 cr in the same quarter last year.
    • financial-insightsThe debt to equity of the company is lower than the industry median
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Lotus Eye Hospital And Institute Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 77.28
  • R2
  • 84.67
  • R3
  • 92.33
Pivot69.62
  • S1
  • 62.23
  • S2
  • 54.57
  • S3
  • 47.18
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Lotus Eye Hospital And Institute Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Aashka Hospitals
Neutral
105.90-247.81104.962.57-8.59
Fortis Malar Hospitals
Bullish
85.690.07160.6020.881.4649.72-
Lotus Eye Hospital And Institute
Bearish
65.970.29137.1947.182.31-1.16
Aspira Pathlab & Diagnostics
Moderately Bearish
65.604.8367.52-6.66-20.54
N G Industries
Bearish
161.00-3.7153.9410.861.512.15-
Lotus Eye Hospital And Institute Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Lotus Eye Hospital And Institute is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holding is moderate at 40.22%
    • InsightsPromoter(s) have decreased the stake in the company in last 12 months
    • InsightsFIIs are not invested in this company
    • InsightsMutual Funds are not invested in this company.
    Lotus Eye Hospital And Institute Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-02-12Quarterly Results
    2024-11-12Quarterly Results
    2023-08-14Quarterly Results
    2023-05-24Audited Results & Dividend
    2023-02-13Quarterly Results
    About the company Lotus Eye Hospital And Institute
    • IndustryHealthcare Facilities
    • ISININE947I01017
    • BSE Code532998
    • NSE CodeLOTUSEYE
    Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides various treatments, suchas ReLEx SMILE, Touchfree Laser, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates in various locations, such as Sitra, Coimbatore; RS Puram, Coimbatore; Salem; Tirupur; Mettupalayam; Kochi; Mulanthuruthy; Saravanampatty, and Karur.
    • Management Info
    • Kavetha SundaramoorthyChairman of the Board
    • K.S. RamalingamChief Executive Officer, Additional Executive Director
    • Ramanujam ReghunathanChief Financial Officer
    • M Achuth MenonCompany Secretary, Compliance Officer
    • Sangeetha SundaramoorthyManaging Director, Executive Director
    Lotus Eye Hospital And Institute Share Price FAQs

    Lotus Eye Hospital And Institute is trading at 65.97 as on Thu Apr 17 2025 09:59:26. This is 0.29% upper as compared to its previous closing price of 65.78.

    The market capitalization of Lotus Eye Hospital And Institute is 137.19 Cr as on Thu Apr 17 2025 09:59:26.

    The 52 wk high for Lotus Eye Hospital And Institute is 91.00 whereas the 52 wk low is 53.00

    Lotus Eye Hospital And Institute can be analyzed on the following key metrics -

    • TTM P/E: 264.78
    • Sector P/E: 22.83
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Lotus Eye Hospital And Institute reported a net profit of 2.91 Cr in 2024.

    Quick Links
    EQUITY QUICK LINKS
    Lotus Eye Hospital And Institute QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Lotus Eye Hospital And Institute share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.